Outcomes Study: Health-System Specialty Pharmacy Role in Managing Medications for Weight Loss in Patients Without Evidence of Type 2 Diabetes

Members of our team had the opportunity to present a new poster abstract at the NASP 2024 Annual Meeting held October 6 – 9.

Authors

Andrew Wash, PharmD, PhD | Lauren Bryant, PharmD | Ana I. Lopez-Medina, PharmD, PhD | Carly Giavatto, PharmD | Casey Fitzpatrick, PharmD | Elizabeth Carpenter, PharmD | Nicholas McDonald, PharmD | Brandon Hardin, PharmD | Jessica Mourani, PharmD​

Background

• Approximately three-quarters of U.S. adults are overweight or obese, which has significant economic costs and negative effects on personal health. ¹​
• A comprehensive weight management plan may involve pharmacologic options; however, many of these medications have faced access issues related to drug shortages and high medication costs. ^2,3
• Health-system specialty pharmacy (HSSP) teams expertly navigate these areas and may have a role in the management of medications for weight loss.

Objectives

• To describe a novel HSSP-led chronic disease management (CDM) program for patients without evidence of type 2 diabetes who were prescribed a weight loss medication as part of a comprehensive weight management plan.​

Read about the team’s findings by downloading the outcomes study below.

​